beclomethasone dipropionate + beclomethasone dipropionate (nasal) + ciclesonide + ciclesonide (nasal)

This is a **combination of four corticosteroid medications**, each indicated for respiratory or nasal inflammatory conditions. The combination comprises: - **QVAR** (beclomethasone dipropionate), an inhaled corticosteroid for the maintenance treatment of asthma, reducing airway inflammation. - **Beconase** (beclomethasone dipropionate, nasal), a nasal spray for allergic rhinitis, acting via local suppression of inflammation in nasal tissues. - **Alvesco** (ciclesonide), an inhaled corticosteroid for asthma maintenance therapy, activated in the lungs to decrease airway inflammation. - **Omnaris** (ciclesonide, nasal), a nasal spray indicated for seasonal and perennial allergic rhinitis, with anti-inflammatory activity in nasal mucosa. All four are **synthetic glucocorticoids** that bind to the glucocorticoid receptor, leading to decreased production of pro-inflammatory mediators, reduced edema, and suppression of immune cell infiltration. This combination, while not marketed as a single product, represents the concurrent use of these agents for upper and lower airway inflammatory diseases[2][3][4][6][8][9].

Brand names

AlvescoOmnarisQvarBeconase

Other names

QVAR RediHalerBeconase AQ